International Journal of Biomedical Engineering and Clinical Science

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

The Significance of Exon 17 Mutations Within FVIII Gene in Wasit City Patients with Hemophilia A

Objective: Hemophilia A is an X chromosome-linked disorder caused by different abnormalities in F8 gene, resulting in the absence of impaired molecule production of factor VIII (FVIII) in the plasma, an important protein in the intrinsic coagulation pathway. The hereditary testing of the F8 gene encoding FVIII is utilized for confirmation of HA diagnosis, which fundamentally diminished serious confusions of this disease and at last leading to longer duration of life. Aims of study: Exon 17 mutations in the FVIII gene were detected and analyzed in 10 HA Iraqi patients. Patients and Methods: This study included 10 Iraqi patient with hemophilia A and 5 healthy members as control. This work done in medicine & science college laboratories as well as AL Zahra Hospital. These patients' prior diagnoses were based on DNA testing and family history. Results: During the screening for exon 17 among the HA patients, results showed 6 (60%) from 10 patients had this mutations. Discussion: It has been shown that the severity of F8 gene mutations is also correlated with their types and locations. Our data feature and information emphasize the prominence of exon 17 for its association with HA patients' positive family ancestry, and we are continue to operate for other exons mutations. Conclusions: Our findings are advantageous for prenatal diagnosis, carrier detection, and HA diagnosis. Our research also shows that patients with HA suspicion should undergo F8 gene mutation screening because there is an association between mutations and severity in our case studies.

Hemophilia A, Factor 8 Gene, Exon 17, Point Mutations, Frameshifts Mutations

APA Style

Maysoon Mohammed Hassan. (2023). The Significance of Exon 17 Mutations Within FVIII Gene in Wasit City Patients with Hemophilia A. International Journal of Biomedical Engineering and Clinical Science, 9(3), 60-65.

ACS Style

Maysoon Mohammed Hassan. The Significance of Exon 17 Mutations Within FVIII Gene in Wasit City Patients with Hemophilia A. Int. J. Biomed. Eng. Clin. Sci. 2023, 9(3), 60-65. doi: 10.11648/j.ijbecs.20230903.15

AMA Style

Maysoon Mohammed Hassan. The Significance of Exon 17 Mutations Within FVIII Gene in Wasit City Patients with Hemophilia A. Int J Biomed Eng Clin Sci. 2023;9(3):60-65. doi: 10.11648/j.ijbecs.20230903.15

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Mann, K. G. (1984) in Progress in Hemostasis and Thrombosis, ed. Staet, T. H. (Grune & Stratton, Philadelphia), Vol. 7, pp. 1-23.
2. Sadler, J. E. & Davie, E. W. (1987) in The Molecular Basis of Blood Disease, eds. Stamatoyannopoulos, G., Nienhuis, A. J., Leder, P. & Majerus, P. W. (Saunders, Philadelphia), pp. 575-630.
3. Bicocchi MP, Pasino M, Lanza T, Bottini F, Boeri E, Mori PG, Molinari AC, Rosano C, Acquila M. Analysis of 18 novel mutations in the factor VIII gene. British Journal of Haematology. 2003; 122: 810–7.
4. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361 (9371): 1801–1809.
5. Husain N. Carrier analysis for hemophilia A: ideal versus acceptable. Expert Rev Mol Diagn 2009; 9 (3): 203–7.
6. Bowen DJ. Haemophilia A and haemophilia B: molecular insights. Mol Pathol 2002; 55 (2): 127–44.
7. Brower C, Thompson AR Hemophilia A. 2000 Sep 21 [updated 2008 Mar 25]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.
8. Keeney S, Mitchell M, Goodeve A. UK Haemophilia Center Doctors’ Organization Haemophilia Genetics Laboratory Network. The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors’ organization haemophilia genetics laboratory network. Haemophilia 2005; 11 (4): 387–97.
9. Payne, A. B., Miller, C. H., Kelly, F. M., Michael Soucie, J., and Craig Hooper, W. (2013). The CDC hemophilia a mutation project (CHAMP) mutation list: a new online resource. Hum. Mutat. 34, E2382–E2391. doi: 1002/humu.22247.
10. Andrikovics, H., Klein, I., Bors, A., Nemes, L., Marosi, A., Varadi, A., et al. (2003). Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica 88, 778–784.
11. Oldenburg, J., and El-Maarri, O. (2006). New insight into the molecular basis of hemophilia A. Int. J. Hematol. 83, 96–102. doi: 10.1532/ijh97.06012.
12. Zimmermann, M. A., Oldenburg, J., Muller, C. R., and Rost, S. (2011). Unusual genomic rearrangements in introns 1 and 22 of the F8 gene. Hamostaseologie 31 (Suppl. 1), S69–S73.
13. Higuchi, M., Wong, C., Kochhan, L., Olek, K., Aronis, S., Kasper, C. K., Kazazian, H. H., Jr., & Antonarakis, S. E. (1990) Genomics 6, 65-71.
14. Wong, C., Dowling, C. D., Saiki, R. K., Higuchi, R. G., Erlich, H. A. & Kazazian, H. H., Jr. (1987) Nature (London) 330, pp. 384-386.
15. Mannucci PM, Tuddenham EG. The hemophilias - from royal genes to gene therapy. N Engl J Med. 2001; 344 (23): 1773–1779.
16. R K Saiki 1, D H Gelfand, S Stoffel, S J Scharf, R Higuchi, G T Horn, K B Mullis, H A Erlich. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29; 239 (4839): 487-91.
17. Nataraj AJ, Olivos-Glander I, Kusukawa N, et al. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis. 1999; 20 (6): 1177–85.
18. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE) Hum Mutat. 1994; 3 (2): 83–94.
19. Yee TT, Williams MD, Hill FG, Lee CA, Pasi KJ. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product. Thromb Haemost. 1997; 78 (3): 1027–1029.
20. Koeberl, D. D., Bottema, C. D. K., Ketterling, R. P., Bridge, P. J., Lillicrap, D. P. & Sommer, S. S. (1990) Am. J. Hum. Genet. 47, 202-217.
21. Akkarapatumwong V, Intorasoot S, Oranwiroon S, Thano-Otarakul P, PungAmritt P, et al. (2000) Frameshift mutations with severe and moderate clinical phenotypes in Thai hemophilia A patients. Hum Mutat 16: 530-531.
22. Rossiter, B. J. F., Edwards, A. & Caskey, C. T. (1991) in Molecular Genetic Approaches to Neuropsychiatric Disease, eds. Brosius, J. & Freneau, R. (Academic, New York), in press.
23. Kamal MZ, Ahmad S, Yedavalli P, Rao NM. Stability curves of laboratory evolved thermostable mutants of a Bacillus subtilis lipase. Biochim Biophys Acta. 2010; 1804 (9): 1850–1856.
24. Shen BW, Spiegel PC, Chang CH, Huh JW, Lee JS, Kim J, Kim YH. et al. The tertiary structure and domain organization of coagulation factor VIII. Blood. 2008; 111 (3): 1240–1247.
25. Markoff A, Gerke V, Bogdanova N. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia. 2009; 15 (4): 932–941.